A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy
Clinical trial NCT03191786 · COMPLETED
Trial details
- NCT number
- NCT03191786
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-11
- Primary completion
- 2022-04-30
- Enrollment
- 453
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.